Age, Disease Duration Are Predictors of CKD After Stem Cell Transplant
TUESDAY, Aug. 12, 2025 -- Predictors of chronic kidney disease (CKD) include age and hematologic disease length after hematopoietic stem cell transplantation (HSCT), according to a study published online Aug. 4 in Renal Failure.
Alina Tanase, M.D., Ph.D., from Fundeni Clinical Institute in Bucharest, Romania, and colleagues prospectively assessed a cohort of 197 patients (mean age, 38.7 years; 52.8 percent female) who underwent allogeneic HSCT to explore the incidence and risk factors associated with CKD.
Overall, acute kidney injury was present in 80 percent of patients within three months, and CKD incidence was 11.7 percent (median onset, six months). The researchers found that age (per one year) was the only variable associated with CKD by univariate Cox regression analysis (hazard ratio [HR], 1.06); a trend of association was presented for baseline creatinine (per 1 mg/dL). Positive predictors for CKD included age (per one year; HR, 1.08) and hematologic disease length (per one month; HR, 1.01) in a multivariate Cox regression analysis. Acute lymphoblastic leukemia was a negative predictive factor (HR, 0.37).
"Given the continuously improving oncologic prognosis of these patients, CKD is becoming a challenge in the long-term care after HSCT, compelling for a multidisciplinary approach," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Guidance Issued on Impact, Management of Potassium, Phosphorus in CKD
THURSDAY, Sept. 25, 2025 -- Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney disease (CKD) and managing their...
Machine, Deep Learning Models Improve Prediction of CKD Progression
MONDAY, Sept. 15, 2025 -- Machine learning and deep learning models applied to integrated clinical and claims data can improve prediction of chronic kidney disease (CKD)...
Baxdrostat Reduces Seated Systolic BP in Uncontrolled, Resistant Hypertension
MONDAY, Sept. 8, 2025 -- The addition of baxdrostat, an aldosterone synthase inhibitor, to background therapy yields a significant reduction in seated systolic blood pressure...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.